
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 984 | 901 | 984 | 887 | 1147 | 1690 |
Fund Return | -1.61% | -9.86% | -1.61% | -3.92% | 2.78% | 5.39% |
Place in category | 1508 | 834 | 1508 | 1538 | 1067 | 154 |
% in Category | 74 | 39 | 74 | 85 | 70 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1442549538 | 2.58B | 5.12 | 1.70 | - | ||
MFSM Global Equity Fund I1 USD | 2.22B | 5.47 | -0.45 | 7.25 | ||
MFS Global Equity A1 USD | 2.22B | 4.44 | -1.42 | 6.21 | ||
MFSM Global Equity Fund W1 USD | 2.22B | 5.75 | 4.36 | 7.19 | ||
MFSM European Value Fund W1 USD | 1.98B | 9.06 | 3.09 | 6.49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS S GS Europe CORE Equity Portfolu | 800.95K | 9.73 | 8.02 | 5.94 | ||
Europe Equity Plus Fund A perf acc | 2.51B | 10.92 | 10.64 | 6.16 | ||
JPMorgan InVs Euro SelectEqA AccUSD | 2.27B | 11.35 | 6.45 | 4.77 | ||
JPMorgan InVs Euro SelectEqD AccUSD | 2.27B | 11.21 | 5.63 | 3.98 | ||
JPEurope Equity Plus Fund C perf ac | 2.51B | 6.26 | 7.88 | 6.92 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 3.37 | 83.17 | -4.80% | |
ASML Holding | NL0010273215 | 3.03 | 526.00 | -6.75% | |
Richemont | CH0210483332 | 2.96 | 124.65 | -8.24% | |
Novo Nordisk B | DK0062498333 | 2.78 | 423.4 | -2.00% | |
Sanofi | FR0000120578 | 2.78 | 92.57 | -3.57% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review